Radioembolization for Cholangiocarcinoma
Autor: | Salomao Faintuch, Muneeb Ahmed, Ammar Sarwar, Komal Manzoor, Jeffrey L. Weinstein, A. Ali |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
business.industry Systemic chemotherapy Incidence (epidemiology) Gastroenterology Transarterial Radioembolization digestive system digestive system diseases Hepatic malignancy 030218 nuclear medicine & medical imaging Review article 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Localized disease Medicine Radiology Nuclear Medicine and imaging Surgery In patient Radiology business neoplasms Intrahepatic Cholangiocarcinoma |
Zdroj: | Digestive Disease Interventions. :093-102 |
ISSN: | 2472-873X 2472-8721 |
Popis: | Cholangiocarcinoma is the second most common primary hepatic malignancy which accounts for 13% of total cancer mortality worldwide. Surgical resection is the only curative treatment for localized disease; however, the majority of patients present when the tumor is unresectable. The incidence of the intrahepatic subtype of cholangiocarcinoma is increasing worldwide. Current standard of care in patients with unresectable intrahepatic cholangiocarcinoma is systemic chemotherapy; however, yttrium-90 transarterial radioembolization (Y90-TARE) is under investigation for the treatment of intrahepatic cholangiocarcinoma with promising trials and published clinical experience. This review critically evaluates the role of Y90-TARE in the management of intrahepatic cholangiocarcinoma. |
Databáze: | OpenAIRE |
Externí odkaz: |